FAHUMSCIAn Academic Publisher
Cover of Advances in Animal and Life Sciences
Edited book · FahumSci
Advances in Animal and Life Sciences
Eds. Zia ud Din Sindhu, Muhammad Imran, Muhammad Arif Zafar, Saima YousafISBN 978-627-7745-12-7
Chapter 09pp. 62–66Published 30 December 2025

Physiological Responses and Adaptations to Hypoxia

Mnahel Asghar1, Hafiza Sehar Shakoor2, Asma Hussain2, Nabeela Kauser3, Muhammad Saleem4*, Jawairia Batool5, Noreen Kiran6, Aqsa Saman6

Summary

Hypoxia is a decrease in oxygen availability below cellular needs, causing a complex series of physiological reactions and adaptations affecting many organ systems. This chapter will discuss the various forms of hypoxia, including hypoxic, hemic, circulatory, histogens, and emphasize on their diverse causes and systemic consequences. Acute responses like respiratory hyperventilation and sudden circulatory changes to sustain oxygen supply, whereas chronic adaptations include increased erythropoiesis and angiogenesis mediated by hypoxia-inducible factors. This chapter will also describe metabolic reprogramming in conditions of hypoxia, which shifts cellular energy generation from oxidative phosphorylation to anaerobic glycolysis. It will also focus on neurological impacts such as cognitive impairment and slowed cerebral blood flow. Despite adaptive mechanisms, acute or chronic hypoxia can lead to diseases such as cardiovascular diseases, renal damage, and problems from intermittent hypoxia. Exercise and tracking heights can affect the intensity of the hypoxic response. After understanding these physiological mechanisms and molecular pathways we can design clinical treatments and treatment methods for hypoxia-related diseases.

KeywordsHypoxiaErythropoiesisAngiogenesisHypoxemiaMetabolismAdaptation

INTRODUCTION

Hypoxia is a pathological condition defined by inadequate oxygen availability at the tissue level to ensure proper cellular activity and maintenance of appropriate homeostasis (Mirchandani et al., 2025). It occurs when the oxygen supply to the body decreases from specific thresholds required for metabolic and physiological equilibrium, resulting in decreased cellular respiration and function (Jana & Alayash, 2025). Hypoxia is a low arterial oxygen tension (PaO2 < 60 mm Hg), which inhibits the normal availability of oxygen transport to tissues through hemoglobin and degrades tissue oxygenation (Almudares et al., 2025). This syndrome can be caused by several reasons, including low ambient oxygen (e.g., high altitude), reduced lung ventilation due to some lung track allergies/inflammation or damages, circulatory deficits, or improper cellular oxygen usage due to slow cell response toward oxygen molecule (Sharma et al., 2025). The response to hypoxia varies across different tissues and organs and may include both rapid compensatory mechanisms and long-term adaptations or pathological effects, depending on the severity and duration of oxygen deprivation (Vélez et al., 2025).

CLASSIFICATION OF HYPOXIA

Hypoxia can be differentiated into four basic categories based on its etiology;

Hypoxic (Hypotonic): caused by low atmospheric oxygen then normal pressure, which occurs at high altitudes, or by respiratory diseases that affect oxygen intake (e.g., pneumonia, COPD). This leads to lower arterial oxygen tension (PaO2) (Sarkar et al., 2017).

Haemi hypoxia: can be defined as the blood's loss or decreased oxygen-carrying capability despite normal oxygen tension, which is generally caused by a drop in hemoglobin quantity/quality or functionality. Common reasons include anemia, carbon monoxide poisoning (which generates carboxyhemoglobin and displaces oxygen) and methemoglobinemia (Guo et al., 2023).

Circulatory hypoxia: caused by reduced blood flow to tissues, such as in heart failure, vascular blockage, shock, or disorders that impede microcirculation. Though the oxygen concentration in blood may be appropriate and normal, but due to these hurdles insufficient perfusion of oxygen causes tissue oxygen deficit and in a result organ activity is interrupted (Hohenauer, 2022).

Histogenous hypoxia: occurs when cells become unable to utilize oxygen effectively after getting it from normal blood flow supply, typically owing to toxic substances such as cyanide poisoning, which block cellular oxidative enzymes, inhibiting aerobic respiration (Dechun & Yunxia, 2025).

These categories are widely recognized and used in understanding the underlying processes of oxygen deprivation, directing suitable diagnostic and treatment measures. Because after taking history and examination of symptoms, it becomes easy to put them in categories and try to solve the problem accordingly.

PHYSIOLOGICAL EFFECTS

The physiological effects of hypoxia differ from organ to organ and involve a variety of acute reactions and degenerative implications.

Respiratory System

The respiratory system responds to hypoxia with a complicated collection of processes to adjust for decreased oxygen availability (Kallet et al., 2022).

Acute response: peripheral chemoreceptors in the carotid and aortic bodies detect low arterial oxygen tension and notify the respiratory center in the brainstem. This produces a fast increase in ventilation by hyperventilation, characterized by greater respiratory rate and tidal volume, in order to maximize the oxygen intake from inspired air (Dean & Stavitzski, 2022). Prolonged low oxygen levels can harm the alveolar-capillary membrane, decreasing gas exchange efficiency. This reduces oxygen transport into the circulation, worsening systemic hypoxia (Zhou et al., 2022). Hypoxia can cause V/Q imbalances and leads to inefficient blood oxygenation.

Right-to-left shunting: in some cases, because of some problem with interaction with alveoli, blood skips oxygenated alveoli and enters systemic circulation without getting enough oxygenation (Jolley, 2025).

Impaired diffusion: oedema, inflammation, or fibrosis can cause thickened alveolar walls and limits the oxygen passage across the membranes, in result there will be no oxygen exchange process with blood flow (Dietrich et al.,2025).

Clinical manifestation: common symptoms include dyspnea, tachypnea, and in severe cases, respiratory failure. Chronic hypoxia can cause pulmonary vasoconstriction, alveolar cell rupture, resulting in increased pulmonary vascular resistance and hypertension.

This synchronized reaction reflects the respiratory system's crucial function in detecting hypoxia and alarm us to restore oxygen equilibrium by using artificial methods. However, chronic or severe hypoxia can lead to pulmonary disease with systemic repercussions (Mirchandani et al., 2025).

Cardiovascular System

The cardiovascular system's first response to hypoxia is raising the cardiac output by fast beating to improve oxygen supply to tissues (Melo et al., 2025). This increase is mostly accomplished through tachycardia (higher heart rate), whereas stroke volume (the amount of blood pumped per beat) remains basically constant following acute exposure (Tianyuan et al., 2025). However, it is also reported in literature that beyond 4000 meters altitude, cardiac output decreases considerably due to variables such as reduced stroke volume, which is connected to lower blood volume and increased hypoxic pulmonary vasoconstriction due to gravity and atmospheric pressure change. Blood flow redistribution is a fundamental adaptive response in which circulation prioritizes major organs like the brain and heart and visceral organs over less critical tissues, ensuring that oxygen is delivered to necessary locations (Richalet et al., 2024).

Chronic hypoxia causes pathogenic consequences in the heart by altering calcium handling within cardiac myocytes and compromising mitochondrial activity. These changes contribute to decreased myocardial contractility and increased ventricular stiffness, which may eventually lead to heart failure (Zhao et al., 2023). Hypoxic pulmonary vasoconstriction also puts more strain on the right heart, which can lead to hypertrophy and right heart failure if it lasts long enough. Overall, these cardiovascular adaptations initially protect oxygen transport. However, chronic or severe hypoxia produces maladaptive remodeling and malfunction (Licker et al., 2021).

Hematological System

The primary hematological response to hypoxia is the stimulation of erythropoiesis through enhanced synthesis of erythropoietin (EPO), a glycoprotein hormone generated mostly by specialized fibroblast-like cells in the renal cortex (Watts et al., 2020). Under low oxygen circumstances, hypoxia-inducible factors (HIFs), particularly HIF-2, stabilize and trigger the expression of the EPO gene (Troise et al., 2024). This leads to enhanced circulating EPO levels, which act on erythroid progenitor cells in the bone marrow to stimulate their proliferation, differentiation, and maturation, leading to increased red blood cell (RBC) production (Arias et al., 2024). This mechanism raises blood hemoglobin concentration and oxygen-carrying capacity, which is a necessary response to restore tissue oxygenation (Xu et al., 2025). Changes in pH, CO2 levels, and the concentration of 2,3-diphosphoglycerate (2,3-DPG) inside RBCs can affect hemoglobin's oxygen affinity during hypoxia. Increased 2,3-DPG reduces hemoglobin's affinity for oxygen, creating a rightward shift in the oxygen-hemoglobin dissociation curve, facilitating oxygen unloading to the tissues (Webb et al., 2022). Thus, the hematological system's modifications during hypoxia increase both the number of oxygen carriers and the efficiency of oxygen transport to hypoxic tissues (Vélez et al., 2025).

Metabolic and Cellular Response

Hypoxia-inducible factors (HIFs), a class of transcription factors that organize cellular adaptation to low oxygen, dominate the regulation of metabolic and cellular responses to hypoxia (Egea et al., 2025). Prolyl hydroxylase enzymes hydroxylate HIF-α subunits (HIF-1α, HIF-2α, and HIF-3α) in ambient circumstances, resulting in ubiquitination and destruction. Hypoxia inhibits hydroxylation, stabilizing HIF-α, which then translocates to the nucleus, dimerises with HIF-β, and binds to HREs at target gene promoters to trigger transcription (Gornostaeva et al., 2024).

HIF activation boosts genes involved in angiogenesis, such as vascular endothelial growth factor (VEGF), promoting new blood vessel creation and improving oxygen supply (Bogadi et al., 2025). It also activates glycolytic enzymes, altering cellular metabolism from oxygen-dependent oxidative phosphorylation to anaerobic glycolysis, preserving oxygen and sustaining ATP synthesis under hypoxic situations. Furthermore, HIF induces erythropoietin (EPO) synthesis, which enhances red blood cell formation and increases blood oxygen capacity (Mitroshina & Vedunova, 2024). These metabolic changes and reprogramming are essential for cell survival under oxygen deprivation, fulfilling the need for continuous energy generation while reducing oxidative stress and cellular damage. The HIF system therefore, links oxygen sensing with the genetic and metabolic changes required for tissue homeostasis under hypoxic stress (Lee et al., 2020).

Neurological Effects

Acute hypoxia reduces cognitive functionality of all nervous system by affecting sensory processing of nerves originating from the brain, attention, memory, processing speed, and executive skills (Wang et al., 2022). This disability results from insufficient oxygen flow and availability to the brain, which is extremely sensitive towards oxygen deprivation (Zani et al., 2024). Under acute hypoxia, brain activity in motor neurons, physical executive and inhibitory processing is decreased, and reaction times are delayed, resulting in poorer mental function (Zani et al., 2024). To compensate, cerebral blood flow rises, which improves oxygen supply to the brain. However, this enhanced blood flow might aggravate cerebral oedema in acute hypoxia, potentially worsening neurological consequences (Nimmo & Younsi, 2025).

The length and degree of hypoxia influence the severity of cognitive impairments. Acute hypoxia mostly produces transitory cognitive impairment, but persistent hypoxia may cause greater long-term harm, including structural brain abnormalities such as hippocampal shrinkage (Lu et al., 2025). Delayed verbal and visual memory, sustained attention, and motor control are among the most impaired cognitive areas. Some activities involving inhibition and response time show reduced sensitivity, but are nevertheless affected at greater hypoxia levels (Zani et al., 2024). These neurological reactions to hypoxia highlight the need for oxygen in sustaining cerebral function and the hazards of hypoxic episodes in clinical or high-altitude environments (Zamirska et al, 2025).

CHRONIC ADAPTATIONS VS PATHOLOGIES

Chronic adaptations to hypoxia include physiological changes that improve oxygen delivery and utilization to preserve tissue function despite extended low oxygen availability (Mirchandani et al., 2025). Key adaptations include;

  • Hypoxia-inducible factors (HIFs) activate VEGF to build new blood vessels, improving tissue perfusion and oxygen supply. Capillary density rises in afflicted tissues, allowing for greater oxygen extraction (Polak et al., 2024).
  • In polycythemia, increased erythropoietin synthesis boosts red blood cell production in bulk and also oxygen-carrying capability of red blood cells (Yu et al., 2024).
  • In metabolic adjustments cells change to more efficient oxygen use and increase anaerobic glycolysis, and decrease the oxygen demand but it did not work for the long term (Ahrens and Singer, 2025).

However, either chronic or severe hypoxia has two pathogenic consequences last for a long. First, chronic hypoxia alters calcium gates and mitochondrial function in cardiomyocytes, leading to heart failure and ischemic damage due to a number of respond like cell toxicity (Guo et al., 2024). Secondly, Renal damage occurs when high oxygen abstraction demands lead to medullary hypoxia and acute tubular necrosis (Zhang et al., 2024). Hypoxia can also damage the blood-brain barrier which is very fragile and lead to vascular leakage that causes unfiltered blood flow in the brain, resulting in cerebral oedema and reduced function (Li et al., 2025).

Intermittent hypoxia, as seen in obstreperous sleep apnea, contributes to hypertension, metabolic acidosis, and elevated cardiovascular risk and leading cause of many new diseases (Badran and Gozal, 2025). Vascular permeability modifications can exaggerate serious illness conditions and raise the risk of cerebral infarction (Castillo-González & González-Rey, 2025). Chronic hypoxic adaptations initially support survival and try to maintain body function normality but long term sustained hypoxia often results in tissue damage and organ dysfunction due to increased pathophysiological stress (Burtscher et al., 2022).

MODULATING FACTORS

Exercise under hypoxia worsens the oxygen demand, causing higher respiratory and cardiovascular straining (Kleinnibbelink et al., 2021). To compensate for a lack of oxygen in the organs, the body increases breathing and cardiac output which causes a high heart rate and, in some conditions, can cause heart failure. However, during physical exercise, this demand is even higher, which might exacerbate oxygen desaturation in the blood and tissues (Zhao et al., 2023). Specifically;

  • Exercising under hypoxia causes arterial oxygen desaturation due to poor alveolar oxygen exchange between oxygenated and deoxygenated blood, decreased blood oxygen content, but due to high body activity increased muscle oxygen use (Korivi et al., 2025).
  • Increased cardiac output during exercise can lead to quicker blood flow into alveoli, reducing time for gas exchange and increasing hypoxia even on a worse level (Joyner & Casey, 2015).
  • Exercise exacerbates the impression of dyspnea and pain, frequently leading to premature exhaustion and decreased endurance capacity of red blood cells and sometimes can cause death(Gao et al., 2024).
  • Moderate exercise can enhance oxygenation, cognitive function, and resilience even in acute hypoxia, but performance capability may be limited (Ando et al., 2020).

Exercise can exacerbate hypoxia by increasing oxygen demand; yet, regulated exercise routines may induce adaptive responses in hypoxic conditions, such as better oxygen utilization and ventilatory efficiency over time (Burtscher et al., 2022).

CONCLUSION

Hypoxia causes a variety of physiological reactions and adaptations to sustain oxygen flow to tissues. Acute compensatory mechanisms include increased breathing through carotid and aortic body chemoreceptors, increased cardiac output, and accelerated erythropoiesis induced by renal erythropoietin production. Cellularly, hypoxia causes metabolic reprogramming via hypoxia-inducible factors (HIFs), which activate genes involved in angiogenesis, glycolysis, and red blood cell formation. Chronic adaptations like angiogenesis and polycythemia increase tissue oxygenation, but chronic or severe hypoxia causes disease by affecting cardiac calcium management and mitochondrial function, injuring the kidneys, and reducing neurological function, increasing the risk of cerebral oedema. Exercise exacerbates hypoxic stress by increasing oxygen demand, whereas altitude amplifies hypoxic consequences. Overall, hypoxia triggers a series of reactions that balance oxygen conservation and delivery, but prolonged oxygen deprivation eventually causes tissue damage and organ malfunction. Understanding these pathways at the systemic and molecular levels is very important for clinical understanding, management and treatment of hypoxic diseases.

References

  • Ahrens S and D Singer, 2025. Placental adaptation to hypoxia: the case of high-altitude pregnancies. International Journal of Environmental Research and Public Health 22:214.
  • Almudares F, B Gandhi, J Davies et al., 2025. Oxygen saturation targeting in the neonatal intensive care unit. Journal of Clinical Medicine 14:3975.
  • Ando S, T Komiyama, M Sudoet al., 2020. The interactive effects of acute exercise and hypoxia on cognitive performance: A narrative review. Scandinavian Journal of Medicine and Science in Sports 30:384-98.
  • Arias CF, N Valente-Leal, F Bertocchini et al., 2024. A new role for erythropoietin in the homeostasis of red blood cells. Communications Biology 7:58.
  • Badran M and D Gozal, 2025. Intermittent hypoxia as a model of obstructive sleep apnea: present and future. Sleep Medicine Clinics 20:93-102.
  • Bogadi S, ME Uddin , VV Karri et al., 2025. Hypoxia inducible factor HIF-1α stabilization as a transformative approach in overcoming diabetic wound healing challenges. Journal of Drug Delivery Science and Technology 26:107296.
  • Burtscher J, RT Mallet, V Pialoux et al., 2022. Adaptive responses to hypoxia and/or hyperoxia in humans. Antioxidants and Redox Signaling 37:887.
  • Castillo-González J and E González-Rey,2025. Beyond wrecking a wall: revisiting the concept of blood-brain barrier breakdown in ischemic stroke. Neural Regeneration Research 20:1944-56.
  • Dean JB & NM Stavitzski, 2022. The O2-sensitive brain stem, hyperoxic hyperventilation, and CNS oxygen toxicity. Frontiers in Physiology13:921470.
    Dechun L & Z. Yunxia, 2025. Pathogenesis and pathophysiology. In: The Pathology and Imaging of Coronavirus Pneumonia (Li H, C Zhang, Y Ma et al., Eds.): Academic Press, London, UK, pp. 27-38.
  • Dietrich J, A Kang, Tielemans B et al., 2025. The role of vascularity and the fibrovascular interface in interstitial lung diseases. European Respiratory Review34:175.
  • Egea V, 2025. HypoxamiRs: the hidden architects of tissue adaptation in hypoxia. Cell Death and Disease16:732.
  • Gao B, S Wang, S Jiang, 2024. The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea. Medical Review 4:395.
  • Gornostaeva A, L Buravkova, M Lobanova et al., 2024. HIFs in hypoxic regulation of the extracellular matrix: focus on little-known player HIF-3. Biocell 48:677-92.
  • Guo L, J Sun, Z He, Q Shi, et al., 2023. Understanding acute respiratory distress syndrome in high-altitude environments: a comprehensive review of diagnosis and treatment. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 29:e939935.
  • Guo Z, Y Tian, N Liu et al., 2024. Mitochondrial stress as a central player in the pathogenesis of hypoxia-related myocardial dysfunction: new insights. International Journal of Medical Sciences 21:2502.
  • Hohenauer E, 2022. Physiological adaptions to acute hypoxia. In: Exercise Physiology (Ferraz R, Ed.) IntechOpen, London, UK, pp. 37.
  • Jana S & AI Alayash, 2025. Exploring the Molecular Interplay Between Oxygen Transport, Cellular Oxygen Sensing, and Mitochondrial Respiration. Antioxidants and Redox Signaling 42:730.
  • Jolley C, 2025. Respiratory physiology. In: Ernsting's Aviation and Space Medicine (Jolley C, Ed.): CRC Press, Florida, USA, pp. 28-47.
  • Joyner MJ & DP Casey, 2015. Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs. Physiological Reviews 95:549-601.
  • Kallet RH, RD Branson, MS Lipnick, 2022. Respiratory drive, dyspnea, and silent hypoxemia: a physiological review in the context of COVID-19. Respiratory Care 67:1343.
  • Kleinnibbelink G, AP van Dijk, A Fornasiero et al., 2021. Exercise-induced cardiac fatigue after a 45-minute bout of high-intensity running exercise is not altered under hypoxia. Journal of the American Society of Echocardiography 34:511.
  • Korivi M, MK Ghanta, P Nuthalapati et al., 2025. Influence of exercise on oxygen consumption, pulmonary ventilation, and blood gas analyses in individuals with chronic diseases. Life 15:1255.
  • Lee P, NS Chandel, MC Simon, 2020. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nature Reviews Molecular Cell Biology 21:268.
  • Li Z, J Zhang, X Zhang et al., 2025. Oxygen metabolism abnormalities and high-altitude cerebral edema. Frontiers in Immunology 16:1555910.
  • Licker M, A Hagerman, A Jeleff et al., 2021. The hypoxic pulmonary vasoconstriction: From physiology to clinical application in thoracic surgery. Saudi Journal of Anaesthesia 15:250-63.
  • Lu G, G Rili, M Shuang, 2025. Impact of hypoxia on the hippocampus: A review. Medicine 104:41479.
  • Melo PH, M Kachel, K Nowak et al., 2025. Effects of intracoronary supersaturated oxygen therapy on myocardial blood flow, microvascular obstruction, and myocardial salvage in ST‐segment-elevation myocardial infarction in swine ischemia/reperfusion model. Journal of the American Heart Association 14:038891.
  • Mirchandani AS, MA Sanchez-Garcia, SR Walmsley, 2025. How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia. Nature Reviews Immunology 25:161.
  • Mitroshina EV & MV Vedunova, 2024. The role of oxygen homeostasis and the HIF-1 factor in the development of neurodegeneration. International Journal of Molecular Sciences 25:4581.
  • Nimmo A & A Younsi, 2025 The Relationship Between Inflammation and the Development of Cerebral Ischaemia and Hypoxia in Traumatic Brain Injury-A Narrative Review. International Journal of Molecular Sciences 26:8066.
  • Polak M, JE Karbowniczek, U Stachewicz, 2024. Strategies in electrospun polymer and hybrid scaffolds for enhanced cell integration and vascularization for bone tissue engineering and organoids. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 16:2022.
  • Richalet JP, E Hermand, FJ Lhuissier, 2024. Cardiovascular physiology and pathophysiology at high altitude. Nature Reviews Cardiology 21:75.
  • Sarkar M, N Niranjan, PK Banyal, 2017. Mechanisms of hypoxemia. Lung India 34:47-60.
  • Sharma D, A Yadav, A Kumari et al., 2025. Cardiopulmonary diseases and high altitude: unresolved issues. In: Health and Sustenance in Extreme Environment: A Military Perspective (Srivastava S, M Sharma & R Varshney, Eds.): Springer, Singapore, pp. 243.
  • Tianyuan WA, MA Ji, SO Yafeng, 2025.Acute Hypoxic exposure and right ventricular adaptation: morphological remodeling, functional dynamics, and hemodynamic implications in healthy individuals. Physiological Research 74:539.
  • Troise D, B Infante, S Mercuri et al., 2024. Hypoxic inducible factor stabilization in pericytes beyond erythropoietin production: The good and the bad. Antioxidants 13:537.
  • Vélez ICV, CMC Domínguez, MJF Sánchez et al., 2025. Hypoxia and Tissue Regeneration: Adaptive Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences 26:9272.
  • Wang X, L Cui & X Ji, 2022. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Metabolic brain disease 37:51.
  • Watts D, D Gaete, D Rodriguez et al., 2020. Hypoxia pathway proteins are master regulators of erythropoiesis. International Journal of Molecular Sciences 21:8131.
  • Webb KL, PB Dominelli, SE Baker et al., 2022. Influence of high hemoglobin-oxygen affinity on humans during hypoxia. Frontiers in Physiology 12:763933.
    Xu Y, Z Yu, H Liu, et al., 2025. Erythrocytes enhance oxygen-carrying capacity through self-regulation. Frontiers in Physiology 16:1592176.
  • Yu S, Y Ye, T Wuren, 2024. Alteration in the number, morphology, function, and metabolism of erythrocytes in high-altitude polycythemia. Frontiers in Physiology 15:1359357.
  • Zamirska W, N Hornig & A Kołodziej, 2025. The impact of hypoxia on psychological and cognitive functioning in high-altitude climbers. Journal of Education, Health and Sport 79:58404.
  • Zani A, Y Dishi & AM Proverbio, 2024. From oxygen shortage to neurocognitive challenges: behavioral patterns and imaging insights. Frontiers in Cognition 3:1468306.
  • Zhang YY, PP Jin, DZ Guo, 2024. Modified Zhenwu Tang delays chronic renal failure progression by modulating oxidative stress and hypoxic responses in renal proximal tubular epithelial cells. Heliyon 10:31265.
  • Zhao Y, W Xiong, C Li et al., 2023. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. Signal Transduction and Targeted Therapy 8:431.
  • Zhou W, T Yu, Y Hua et al., 2022. Effects of hypoxia on respiratory diseases: perspective view of epithelial ion transport. American Journal of Physiology-Lung Cellular and Molecular Physiology 323:240.